New data on ctDNA as a biomarker for detecting cancer progression

09:00 EDT 11 Jul 2019 | ecancermedicalscience

Scientists presented more than 30 abstracts featuring Bio-Rad's Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Many of these studies used liquid biopsy powered by the ddPCR platform...

Original Article: New data on ctDNA as a biomarker for detecting cancer progression

More From BioPortfolio on "New data on ctDNA as a biomarker for detecting cancer progression"